Introduction —
This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Delirium and confusional states in older adults".)
International
●World Health Organization (WHO): Preferred product characteristics of blood-based biomarker diagnostics for Alzheimer disease (2024)
●Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia – A collaborative international guideline (2023)
●International practice recommendations for the recognition and management of hearing and vision impairment in people with dementia (2022)
●WHO: Guidelines on risk reduction of cognitive decline and dementia (2019)
●WHO: A guide towards a dementia plan (2018)
●WHO: The global dementia observatory reference guide (2018)
Canada
●Alzheimer Society of Canada (ASC): National dementia guidelines – Disclosing and communicating a diagnosis of dementia (2024)
●Canadian Coalition for Seniors' Mental Health (CCSMH): Canadian clinical practice guidelines for assessing and managing behavioural and psychological symptoms of dementia (BPSD) (2024)
●Canadian Task Force on Preventive Health Care (CTFPHC): Recommendations on screening for cognitive impairment in older adults (2016, reaffirmed 2024)
●Choosing Wisely Canada: Canadian Nurses Association (CNA) – Twelve tests and treatments to question in nursing (updated 2024)
●Choosing Wisely Canada: Canadian Geriatrics Society (CGS) – Eight tests and treatments to question (updated 2022)
●Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD): Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia (2020)
●ASC: Guidelines for care – Person-centred care of people with dementia living in care homes (2011)
United States
●Emergency Nurses Association (ENA): Clinical practice guidelines for screening older adults for cognitive impairment
●Alzheimer's Association (ALZ): Revised criteria for diagnosis and staging of Alzheimer's disease (2024)
●American College of Radiology (ACR): ACR Appropriateness Criteria on dementia (revised 2024)
●American Heart Association (AHA): Scientific statement on aggressive LDL-C lowering and the brain – Impact on risk for dementia and hemorrhagic stroke (2023)
●AHA/American Stroke Association (ASA): Scientific statement on cognitive impairment after ischemic and hemorrhagic stroke (2023)
●National Institute on Aging (NIA): Assessing cognitive impairment in older patients (2023)
●NIA: Caring for older patients with cognitive impairment (2023)
●American Academy of Neurology (AAN): Practice parameter: Evaluation and management of driving risk in dementia, update (2010, reaffirmed 2022)
●AHA/ASA: Scientific statement for endovascular treatment and thrombolysis for acute ischemic stroke in patients with premorbid disability or dementia (2022)
●American Psychological Association (APA): Guidelines for the evaluation of dementia and age-related cognitive change (2021)
●American Urogynecologic Society (AUGS): Clinical consensus statement – Association of anticholinergic medication use and cognition in women with overactive bladder (2021)
●NIA: Diagnosing Lewy body dementia – For professionals (2021)
●ACR-American College of Nuclear Medicine (ACNM)-American Society of Neuroradiology (ASNR)-Society of Nuclear Medicine and Molecular Imaging (SNMMI): Practice parameter for brain PET/CT imaging in dementia (2015, revised 2020)
●US Preventive Services Task Force (USPSTF): Final recommendation statement on cognitive impairment in older adults – Screening (2020)
●ALZ: Dementia care practice recommendations (2018)
●American Psychiatric Association (APA): Practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia (2016)
●American Geriatrics Society (AGS): Feeding tubes in advanced dementia position statement (2014)
Europe
●European Society for Clinical Nutrition and Metabolism (ESPEN): Guideline on nutrition and hydration in dementia, update (2024)
●European Stroke Organisation (ESO) and European Academy of Neurology (EAN): Joint guidelines on post-stroke cognitive impairment (2021)
●EAN: Guideline on medical management issues in dementia (2020)
●European Association of Nuclear Medicine (EANM) and EAN: Recommendations for the use of brain 18F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia – Delphi consensus (2018)
●European Federation of Neurological Societies (EFNS)-European Neurological Society (ENS)/EAN: Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease (2015)
●EFNS-ENS: Guidelines on the diagnosis and management of disorders associated with dementia (2012)
●EFNS: Guidelines for the diagnosis and management of Alzheimer's disease (2010)
United Kingdom
●Scottish Intercollegiate Guidelines Network (SIGN): Assessment, diagnosis, care and support for people with dementia and their carers – A national clinical guideline (2023)
●National Institute for Health and Care Excellence (NICE): Quality standard on dementia (2019)
●NICE: Guideline on dementia – Assessment, management and support for people living with dementia and their carers (2018)
●NICE: Guideline on dementia, disability and frailty in later life – Mid-life approaches to delay or prevent onset (2015)
India
●Indian Psychiatric Society (IPS): Clinical practice guidelines on cognitive therapy and family intervention for patients with dementia and psychosis (2020)
●IPS: Clinical practice guidelines for management of dementia (2018)
Australia–New Zealand
●Royal Australian College of General Practitioners (RACGP): Guidelines for preventive activities in general practice – Dementia, 10th edition (2024)
●Australian National Health and Medical Research Council (NHMRC): Clinical practice guidelines and principles of care for people with dementia – Recommendations (2016)
●Choosing Wisely Australia: Do not use antipsychotics as the first choice to treat behavioural and psychological symptoms of dementia (2016)
●Choosing Wisely Australia: Don't initiate and continue antipsychotic medicines for behavioural and psychological symptoms of dementia for more than 3 months (2016)
Japan
●[In Japanese] Japanese Society of Neurology (JSN): Guidelines for proper use of amyloid PET imaging agents (2023)
●[In Japanese] JSN: Guidelines for the proper use of cerebrospinal fluid and blood biomarkers related to dementia (2021)
●[In English] JSN: Clinical practice guideline for dementia (2017)
●[In Japanese] JSN: Clinical practice guideline for dementia (2017)
●[In Japanese] Choosing Wisely Japan: Tube feeding for Alzheimer's patients – When to use it and when not to use it (2016)
